Instil Bio (TIL) Share-based Compensation (2020 - 2026)
Instil Bio (TIL) posted quarterly Share-based Compensation of $985000.0 for Q1 2026, down 71.82% year-over-year from $3.5 million in Q1 2025, and down 38.67% quarter-over-quarter from $1.6 million in Q4 2025.
Instil Bio (TIL) Share-based Compensation (2020 - 2026) Analysis & Trends
Instil Bio's Share-based Compensation history runs 7 years deep, the most recent figure standing at $985000.0 for Q1 2026.
- In Q1 2026, Share-based Compensation fell 71.82% year-over-year to $985000.0; the TTM figure through Mar 2026 stood at $6.2 million (down 61.92% YoY), while the FY2025 annual figure was $8.7 million, down 49.63% from the prior year.
- Share-based Compensation for Q1 2026 stood at $985000.0, down from $1.6 million in the prior quarter.
- The five-year high for Share-based Compensation was $8.3 million in Q2 2022, with the low at $985000.0 in Q1 2026.
- The 5-year median for Share-based Compensation is $4.5 million (2024), against an average of $4.4 million.
- The sharpest annual moves came in 2022 and 2026: Share-based Compensation soared 166.47% in 2022, then sank 71.82% in 2026.
- Instil Bio's Share-based Compensation stood at $6.6 million in 2022, then tumbled by 31.46% to $4.6 million in 2023, then declined by 1.14% to $4.5 million in 2024, then plunged by 64.32% to $1.6 million in 2025, then slumped by 38.67% to $985000.0 in 2026.
- Business Quant data shows TIL's Share-based Compensation at $985000.0 in Q1 2026, $1.6 million in Q4 2025, and $1.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 108.10 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 243.00 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 120.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 137.41 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 86.63 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 41.25 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 28.05 Mn |
| 10 | Instil Bio | 50.29 Mn | 50.29 Mn | - | 1.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.23 Mn |
| Jun 30, 2026 | 1.23 Mn |
| Mar 31, 2026 | 985,000.00 |
| Mar 31, 2026 | 985,000.00 |
| Dec 31, 2025 | 1.61 Mn |
| Dec 31, 2025 | 1.61 Mn |
| Sep 30, 2025 | 1.77 Mn |
| Sep 30, 2025 | 1.77 Mn |
| Jun 30, 2025 | 1.82 Mn |
| Jun 30, 2025 | 1.82 Mn |
| Mar 31, 2025 | 3.50 Mn |
| Mar 31, 2025 | 3.50 Mn |
| Dec 31, 2024 | 4.50 Mn |
| Dec 31, 2024 | 4.50 Mn |
| Sep 30, 2024 | 4.07 Mn |
| Sep 30, 2024 | 4.07 Mn |
| Jun 30, 2024 | 4.17 Mn |
| Jun 30, 2024 | 4.17 Mn |
| Mar 31, 2024 | 4.52 Mn |
| Mar 31, 2024 | 4.52 Mn |